Raju Kandimalla - Concepedia

Author

Raju Kandimalla

Baylor University Medical Center ORCID

Also Known As

R Kandimalla, R. Kandimalla, RAJU KANDIMALLA, RAMESH KANDIMALLA, Raju Kandimalla

190

Publications

Citations

H-Index

Concepts

All Affiliations

Baylor University Medical Center Baylor Medical Center at Garland City University of Hong Kong Erasmus MC Kumamoto University

About

Raju Kandimalla is an author at Baylor University Medical Center specializing in medicine, oncology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	668
2	Pathology	7	7	537
3	Engineering	4	4	253
4	Cell Biology	3	3	258
5	Immunology	1	1	98

Raju Kandimalla

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Intratumoral <i>Fusobacterium Nucleatum</i> Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma Kensuke Yamamura, Daisuke Izumi, Raju Kandimalla, Clinical Cancer Research	2019	187
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models Janneke F. Linnekamp, Sander R. van Hooff, Pramudita R. Prasetyanti, Cell Death and Differentiation Vivo ModelsOncologyTumor HeterogeneityMedicineConsensus Molecular Subtypes	2018	176
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers Raju Kandimalla, Angela A.G. van Tilborg, Lucie C. Kompier, European Urology UrologyEngineeringMedicineEpigenomicsCancer Genomics	2012	105
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes Tsuyoshi Ozawa, Raju Kandimalla, Feng Gao, Gastroenterology OncologyMedicineImmunologyMicrorna Signature AssociatedColorectal Cancer	2017	98
<i>FGFR3</i> , <i>TERT</i> and <i>OTX1</i> as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study Willemien Beukers, Kirstin A. van der Keur, Raju Kandimalla, The Journal of Urology	2017	88
Novel evidence for m6A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer Tadanobu Shimura, Raju Kandimalla, Yoshinaga Okugawa, British Journal of Cancer M6a Methylation RegulatorsPrognostic BiomarkersOncologyGastrointestinal OncologyMedicine	2021	60
A 3-Plex Methylation Assay Combined with the <i>FGFR3</i> Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine Raju Kandimalla, Roy Masius, Willemien Beukers, Clinical Cancer Research	2013	59
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype Evelyn Fessler, Marnix Jansen, Felipe de Sousa e Melo, Oncogene Tumor BiologyFunctional GenomicsOncologyEngineeringMedicine	2016	56
Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer Willemien Beukers, Raju Kandimalla, Roy Masius, Modern Pathology UrologyGenitourinary CancerMedicinePathologyCancer Genomics	2014	55
Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer Tadanobu Shimura, Shusuke Toden, Raju Kandimalla, Annals of Surgery EngineeringGenomewide Expression ProfilingPathologyGene Expression ProfilingTumor Biology	2019	51

Page 1